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ABSTRACT 
 
Ethnopharmacological relevance: The stem bark of Garcinia livingstonei is used traditionally as a 
skin lightening agent. 
Aim of the study: To isolate and identify compounds responsible for the observed skin lightening 
activity of Garcinia livingstonei and to evaluate their cytotoxicity. 
Materials and Methods: Constituents of the stem bark and fruits of Garcinia livingstonei were 
isolated using chromatographic techniques and structures were determined using 1D and 2D NMR 
and MS analysis. MeWo cells were used to evaluate the cytotoxicity and impact on melanin levels of 
extracts and compounds isolated, in vitro. 
Results: Twelve known compounds, morelloflavone (1), morelloflavone-7”-sulphate (2), guttiferone 
A (3), sargaol (4), isojacareubin (5), 6-deoxyisojacareubin (6) and in addition to the common 
triterpenoids, betulin, betulin aldehyde, lupeol, lupenone, euphol and stigmasterol were isolated in 
this investigation.  Morelloflavone, morelloflavone-7”-sulphate and sargaol, were found to be 
considerably less cytotoxic and more effective as skin lightening agents than hydroquinone.   
Conclusions: A range of compounds was isolated from the stem bark and fruit of Garcinia 
livingstonei.  Although the bark extract contained the cytotoxic guttiferone A, it was found to be less 
toxic than hydroquinone, and morelloflavone, the 7”-sulphate derivative and sargaol show potential 
for development as depigmentation/skin lightening agents. 
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1. Introduction 
Garcinia livingstonei T. Anderson (syn. G. angolensis Vesque)(Clusiaceae) is found throughout 
tropical Africa, where it occurs as a distinctive small to medium sized (2–10 m) evergreen tree in low 
altitude riverine fringes and open woodlands (Palgrave, 2002).  It is known variously in South Africa 
as the African or Lowveld Mangosteen, and umPhimbi, isiHlumanye or uGobandlovu (isiZulu) 
(Pooley, 1993; Hutchings et al., 1996).  The wood is used as a general purpose timber, while the 
flesh of the pinkish orange fruit is edible, with a refreshing acid-sweet taste, and can also be 
fermented to prepare a pleasant alcoholic beverage (Palgrave, 2002). 
 
The powdered root is used as an aphrodisiac in the treatment of impotence (Arnold and Gulumian, 
1984), for abdominal pains during pregnancy (Samuelsson et al., 1992), and as an aid in childbirth 
(Yu, 1982), while steam from a decoction of the dried leaves is used to treat watering eyes (Arnold 
and Gulumian, 1984). Coughs, fevers and parasitic diseases are treated with infusions of the fruits 
and stems (Iwu, 1993). 
 
Previous investigations of this species have resulted in the isolation of a variety of bioactive 
oxygenated aromatic compounds.  A series of novel prenylated xanthones was isolated from 
Garcinia livingstonei which showed fungiostatic activity against Cladosporium cucumerinum 
comparable to that of miconazole, and inhibited SW 480 human colon carcinoma cell growth at 
levels similar to that of 5-fluorouracil (Sordat-Diserens et al., 1992a).  Sordat-Diserens et al. (1992b) 
isolated the xanthone dimer garcilivin A, which has since been shown to display trypanosomal 
activity against T. brucei brucei (Mbwambo et al., 2006).  Bioassay-guided fractionation of the fruit 
has yielded the HIV-inhibitory tetraprenylated benzophenone guttiferone A (3) (Gustafson et al., 
1992), and the biflavanoid ent-naringeninyl-(I-3α,II-8)-4’-O-methylnaringenin  which is moderately 
active against a Ghanaian CQS strain of P. falciparum (Mbwambo et al., 2006). 
 
Several tree species are used traditionally on the eastern seaboard of South Africa for the treatment 
of skin diseases and cosmetic purposes, such as for skin lightening, often under the Xhosa and Zulu 
name umemezi (Earle, 1976; Khan, 1996; Cocks & Dold, 2004; Momtaz et al., 2008).  Although a 
highly valued ethnomedicinal species (Hutchings et al., 1996), dermatological uses for Garcinia 
livingstonei have not earlier been documented either locally, or elsewhere in its extensive tropical 
African range.  Only recently has its application in skin treatment been reported through a personal 
communication to one of us (NCD) in her capacity as a dermatologist.  Clinical observations (Dlova, 
2002, unpublished results) have revealed that a water slurry of the powdered stem bark is an 
effective facial sunscreen and/or skin lightener.  A literature search indicated that other Garcinia 
species such as Garcinia indica Choisy (Jain & DeFilipps, 1991) are used to treat skin diseases, with 
two taxa, the African Garcinia kola Heckel and the Asian G. subelliptica Merr. reported to yield 
tyrosinase inhibitors, from leaves and fruit respectively (Masuda et al., 2005; Okunji et al., 2007).  
 
As no previous studies have focused on this aspect of the use of G. livingstonei, the current work was 
carried out with the aim of isolating compounds for screening for possible application in skin-
lightening preparations.  
 
Disorders of hyperpigmentation are seen in all skin types; however, they are encountered more 
frequently in skin of color (Kanthraj, 2010).  While no single therapy has been shown to be superior 
or to be of benefit to all patients, sometimes combination therapy is recommended to maximize the 
management of complex cases (Sheth & Pandya, 2011).  The main goal of treatment is to decrease 
the hyperpigmentation with minimal side effects.  A range of topical agents are available to treat 
hyperpigmentation and act at different levels of the melanogenesis pathway (Kanthraj, 2010; Sheth 
& Pandya, 2011).  The most common synthetic pharmacologic agents used are hydroquinone, 
corticosteroids, and mercurials (Olumide et al., 2008).  The long-term use of these products may 
cause undesirable cutaneous or systemic side effects (Findlay et al., 1975; Findlay & de Beer, 1980; 
Olumide et al., 2008).  
 
p-Hydroquinone (1,4-dihydroxybenzene) was one of the earliest products used for the treatment of 
hyperpigmentation and remains the standard against which other treatments for hyperpigmentation 
are measured. (Draelos, 2007; Sheth & Pandya, 2011).  However, its use has been associated with 
various side effects, which include irritant contact dermatitis and exogenous ochronosis (Findlay & 
de Beer, 1980; Hardwick et al., 1989; Olumide et al., 2008).  In 1975, Findlay and co-workers 
reported ochronosis amongst black South African women after prolonged use of skin lightening 
creams containing p-hydroquinone, which inhibits tyrosinase and prevents the conversion of tyrosine 
to dihydroxyphenylalanine, a precursor of melanin.  Tyrosinase is, accordingly, a potential target in 
the search for a medically acceptable skin lightening agent from natural sources.  This subject has 
been the focus of a recent review (Smit et al., 2009). 
 
Given the problems related to hydroquinone use, there exists a need for the identification of novel 
agents that can be used as skin lightening products, either for cosmetic or clinical use.  In this work 
we examine the properties of compounds isolated from Garcinia livingstonei, measuring both their 
ability to both alter melanin levels in human melanoma cells, and their relative cytotoxicity. 
 
2. Experimental section 
2.1 Plant material 
Stembark of Garcinia livingstonei T. Anderson was collected in Zululand, KwaZulu-Natal Province, 
South Africa, in June 2002, and fruits were collected on the Howard College Campus of the 
University of KwaZulu-Natal in January 2004.  Plant material was identified by Professor Neil 
Crouch and vouchers for bark (N. Crouch 942) and fruit (N. Crouch 1137) lodged at the KwaZulu-
Natal Herbarium (NH) in Durban.   
 
2.2  Isolation of Compounds 
The stem bark was air-dried at room temperature and milled, while the fresh fruits were first peeled 
and the nut-like kernels separated from the surrounding fruit flesh. The dry powdered stem bark 
(0.65 kg) was successively extracted with dichloromethane, ethyl acetate and methanol for twenty-
four hours each, using a Soxhlet apparatus, and the solvents concentrated in vacuo to yield 14.6, 18.7 
and 62.2 g of extract, respectively.  1H NMR and tlc analysis showed that the ethyl acetate and 
methanol extracts of the stem bark were very similar, and they were combined.  Fresh seed kernels 
(1.2 kg), obtained as described above, were successively extracted in similar fashion with hexane, 
dichloromethane, ethyl acetate and methanol, yielding 38.9, 2.2, 6.4 and 50.0 g of extract, 
respectively.  The fresh fruit peel (1 kg wet mass) was soaked in methanol overnight, filtered, and the 
filtrate concentrated in vacuo to give a suspension, which was extracted with ethyl acetate and 
concentrated in vacuo, yielding 18.8 g of extract.   
 
Repeated separation by gravity column normal phase (Merck 9385 Si gel) and size exclusion 
(Sephadex LH-20) chromatography, and semi-preparative scale tlc (Merck 05554 aluminium-backed 
tlc plates) was undertaken using hexane:dichloromethane:ethyl acetate:acetone:methanol solvent 
mixtures.  The dichloromethane extract of the stem bark yielded betulin, (2.5 g), betulin aldehyde (5 
mg), lupeol (5 mg), lupenone (5 mg), euphol (50 mg) and stigmasterol (120 mg).  The combined 
ethyl acetate/methanol extract of the stem bark yielded morelloflavone (1) (20 mg) and 
morelloflavone-7”-sulphate (2) (20 mg).  Guttiferone A (3) (5 mg) was isolated from the fruit peel 
extract. The hexane extract of the fruit kernels yielded sargaol (4) (50 mg) and isojacareubin (5) (5 
mg) and 6-deoxyisojacareubin (6) (5 mg) were isolated from the dichloromethane extract. 
 
2.3 Identification of Compounds isolated. 
NMR anaylsis was performed on a Bruker 400 MHz NMR spectrophotometer and spectra were 
determined in CDCl3 or CD3OD.  HRMS were recorded on a Finnigan MAT 95 XP high resolution 
Double Focussing MS at the University of Surrey.  Structures of compounds isolated were confirmed 
by comparison of NMR and MS data against literature values as referenced in Section 3.  
 
2.4 In-vitro screening of compounds isolated  
A human granular fibroblast cell line derived from malignant melanoma was used in all in vitro 
assays (MeWo; ECACC No: 93082609) and was purchased from ECACC (Porton Down, UK). Cells 
were grown in EMEM supplemented with 2mM glutamine, 1% non-essential amino acids, 10% 
foetal bovine serum and 100U/ml penicillin, 100 µg/ml streptomycin. All cell culture medium and 
supplements were purchased from Invitrogen (Paisley, UK). MeWo cells were seeded into 96-well 
plates (Nunc International, Leicestershire, UK) at a concentration of 10,000 cells/well and incubated 
at 37 °C for 48 hrs in a humidified container for attachment.  Chemicals/crude extracts or vehicle 
(0.1 % DMSO) was then added to the wells at the indicated concentrations and cells incubated for a 
further forty-eight hours. Following exposure, medium was collected and cytotoxicity determined by 
LDH-leakage using the cytotoxicity detection kit (Roche, Lewes, Sussex, UK), as per the 
manufacturer’s instructions.  For evaluation of melanin content, cells were washed with PBS, lysed 
with 1N NaOH and centrifuged to remove cellular debris.  The melanin content of the supernatant 
was then determined by optical density at 405 nm (Takiwaki et al., 2004). 
 
3. Results and Discussion 
Twelve known compounds, morelloflavone (1) (Li et al., 2002), morelloflavone-7”-sulphate (2) (Li 
et al., 2002), guttiferone A (3) (Gustafson et al., 1992), sargaol (2-geranyl-6-hydroxy-2,8-dimethyl-
chromene) (4) (Numuta et al., 1992; Voutquenne et al., 1999), isojacareubin (5) (Helesbeux et al., 
2004), 6-deoxyisojacareubin (6) (Ishiguro et al., 1993) and the common triterpenoids, betulin, betulin 
aldehyde, lupeol, lupenone, euphol and stigmasterol were isolated in this investigation  The 
structures of the isolated compounds were established using NMR spectroscopy and mass 
spectrometry and by comparison against literature data as referenced above. 
 
In addition to its HIV-inhibitory activity (Gustafson et al., 1992), guttiferone A (3) has also been 
shown to be a potent inhibitor of cholinesterase (Lenta et al., 2007) and glutathione transferase 
enzymes (Muleya et al., 2008), as well as exhibiting antioxidant (Ngouela et al., 2006), 
leishmanicidal (Lenta et al., 2007), antiplasmodial (Ngouela et al., 2006), trypanocidal (Abe et al., 
2004), and cytotoxic (Williams et al., 2003) effects.  The activity of morelloflavone (1) as an anti-
inflammatory (Gil et al., 1997; Castardo et al., 2008) and antioxidant (Sanz et al., 1994; Deachathai 
et al., 2005; Hutadilok-Towatana et al., 2007) are well-documented; it has also been found to be a 
potent tyrosinase inhibitor (Masuda et al., 2005), anti-HIV-1 (Lin et al., 1997), and anti-bacterial 
(Verdi et al., 2004) agent, and to have antimalarial (Ngouamegne et al., 2008) and analgesic (Luzzi 
et al., 1997) properties.  Isojacareubin (5) is known for its activity as an anticoagulant (Wu et al., 
1998), and 6-deoxyisojacareubin (6) for its antifungal (Morel et al., 2002) and antibacterial (Kuete et 
al., 2007) properties, while sargaol (4) shows marked activity as an antioxidant (Nahas et al., 2007). 
 
Morelloflavone (1), morelloflavone-7”-sulphate (2),  guttiferone A  (3), and sargaol (4) together with 
the ethyl acetate  and methanol extracts of G. livingstonei stem bark (crude extracts 39b and 39c 
respectively), and the fruit peel extract, were selected for further in vitro analysis. MeWo cells, a 
human malignant melanoma cell line, were selected to investigate the action of these compounds and 
extracts in vitro, both in terms of impact on melanin levels and overall cytotoxicity. The melanin 
content of the melanocytes was determined after dosing these cells with known concentrations of the 
test extracts/compounds, whereas the cytotoxicity assay was based on the measurement of lactate 
dehydrogenase (LDH) released from the cytosol of damaged cells into the culture medium:  Full 
details of the procedures used are given in the Experimental section. 
 
Prior to examining the derived compounds and extracts, the response of MeWo cells to the classical 
pro-oxidant and skin-lightening agent hydroquinone was examined.  As can be seen from figure 2, 
hydroquinone was able to elicit a dose-dependent decrease in melanin content of the cells, with an 
EC50 = 87±1.3 µM.  This effect on melanin content was accompanied by dose-dependent 
cytotoxicity, with an IC50 = 45±5.4 µM.  
 
Following characterization of the response of MeWo cells to hydroquinone, we next examined the 
effect of the 25 µM for pure chemicals and 100 mg/mL for crude extracts on both melanin content 
and cytotoxicity (Figure 3).  The fruit peel extract was extremely cytotoxic, leading to complete cell 
death within 48 hours and compromising the LDH readings.  In addition, the crude extracts 39b and 
39c were both darkly coloured and their melanin readings were thus also compromised; these results 
will not be discussed further.  As previously observed by Williams and colleagues, guttiferone A was 
shown to be cytotoxic, with 25 µM causing approximately 80% cell death, a value that is consistent 
with the reported IC50 value of approximately 1 µM (Williams et al. 2003). This was the most 
cytotoxic pure chemical examined, with 25 µM exposures of morrelloflavone, morelloflavone -7”-
sulphate and sargaol only causing between 10 – 20 % cell death (Figure 3a).  
 
In addition, all compounds were able to decrease the melanin content of the cells (Figure 3b), 
although to differing extents.  Again, guttiferone A produced the largest decrease, but this interesting 
activity was offset by the large cytotoxic effect observed at the same dose.  Morelloflavone, 
morelloflavone -7”-sulphate and sargaol all caused significant decreases in melanin content 
(approximately 60 % of control; Figure 3), while causing less than 20 % cell death at 25 µM. 
Accordingly, these compounds were selected for a more complete concentration-response 
examination.  Figure 4 shows concentration-response curves for each compound (1 µM to 100 µM), 
with both cytotoxicity (LDH) and melanin content measured.  Morelloflavone, morelloflavone-7”-
sulphate and sargaol all elicited a dose-dependent effect on cytotoxicity and melanin content (Figure 
4a, b, c, respectively).  All three compounds elicited a concentration-dependent decrease in melanin 
content and cytotoxicity in MeWo cells, with morelloflavone-7”-sulphate having the most promising 
profile.  Figure 4b shows a clear separation of the curves for cytotoxicity (IC50 = 41.8±2.5 µM) and 
melanin content (EC50 = 8.6±1.3 µM), suggesting that this compound has the most favourable 
balance of maximal pharmacological effect with minimal toxicological liability.  It should be noted, 
however, that of the three compounds tested morelloflavone-7”-sulphate also elicits the smallest 
absolute change in melanin content, being 74 % of control, compared to 13 % for sargaol; the current 
dose range was insufficient to determine a robust maximal effect for morelloflavone, but it is 
expected to be in excess of 60 %. 
 
4. Conclusion  
Morelloflavone (1), morelloflavone-7”-sulphate (2), guttiferone A (3), and sargaol (4) are all more 
effective in reducing melanin content of MeWo human melanoma cells than hydroquinone.  In 
addition, morelloflavone , morelloflavone-7”-sulphate , and sargaol  are less cytotoxic.  Although 
morelloflavone, isolated from Japanese material of Garcinia subelliptica has previously been shown 
to possess potent tyrosinase inhibitory activity (Masuda et al., 2005), the current investigation 
revealed that morelloflavone-7”-sulphate 7 possessed the best separation between reduction in 
melanin and induction of cell death. 
 
In conclusion, preliminary results show that morelloflavone, morelloflavone-7”-sulphate and sargaol  
are highly effective melanin production inhibitors. When tested in the human melanoma cell line 
MeWo, they inhibit melanogenesis to a greater extent than hydroquinone, whilst causing less 
cytotoxicity. As such, these compounds represent good candidates for further development of novel 
skin lightening agents to be used in the cosmetic and clinical arenas. 
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Figure Legends 
Figure 1: Structures of compounds isolated from Garcinia livingstonei. 
 
Figure 2: The classical pro-oxidant hydroquinone decreases melanin content but is highly toxic 
to MeWo cells. MeWo melanoma cells were exposed to 25-200 µM hydroquinone or vehicle for 48 
hours. Following exposure, cell death was then measured by LDH assay, normalized to vehicle and 
TX100-treated cells, and melanin content by absorbance at 405 nM. Each data point represents n=3 
±SEM, and is representative of at least three independent experiments.  
 
Figure 3: Response of MeWo cells to 25 µM (pure compounds) and 100 mg/mL (extracts) from 
Garcinia livingstonei. MeWo melanoma cells were exposed to 25 µM pure compounds, 100mg/mL 
mixed extracts or vehicle for 48 hours. Following exposure, cell death was then measured by LDH 
assay, normalized to vehicle and TX100-treated cells, and melanin content by absorbance at 405 nM. 
HQ = hydroquinone, Mel = morelloflavone (1), Mel-7-SO4 = morelloflavone-7”-sulphate (2), Sargao 
= sargaol (4), Gutti A = guttiferone A (3), Ext 39b and Ext 39c = ethyl acetate and methanol extracts 
of G. livingstonei stem bark, respectively, Fruit peel = fruit peel (methanolic) ethyl acetate extract. 
Data are representative of at least three independent experiments. 
 
Figure 4: Response of MeWo cells to Morelloflavone, Morelloflavone-7-sulphate and Sargaol 
from Garcinia livingstonei. MeWo melanoma cells were exposed to 1-100 µM of morelloflavone 
(A), morelloflavone-7-sulphate (B), sargaol (C) or vehicle for 48 hours. Following exposure, cell 
death was then measured by LDH assay, normalized to vehicle and TX100-treated cells, and melanin 
content by absorbance at 405 nM. Each data point represents n=3 ±SEM, and is representative of at 
least three independent experiments.  
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structures of compounds isolated from Garcinia livingstonei. 
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Figure 2: The classical pro-oxidant hydroquinone decreases melanin content but is highly toxic 
to MeWo cells. MeWo melanoma cells were exposed to 25-200 µM hydroquinone or vehicle for 48 
hours. Following exposure, cell death was then measured by LDH assay, normalized to vehicle and 
TX100-treated cells, and melanin content by absorbance at 405 nM. Each data point represents n=3 
±SEM, and is representative of at least three independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3: Response of MeWo cells to 25 µM (pure compounds) and 100 mg/mL (extracts) from 
Garcinia livingstonei. MeWo melanoma cells were exposed to 25 µM pure compounds, 100 mg/mL 
mixed extracts or vehicle for 48 hours. Following exposure, cell death was then measured by LDH 
assay, normalized to vehicle and TX100-treated cells, and melanin content by absorbance at 405 nM. 
HQ = hydroquinone, Mel = morelloflavone 6, Mel-7-SO4 = morelloflavone-7”-sulphate 7, Sargao = 
sargaol 10, Gutti A = guttiferone A 4, Ext 39b and Ext 39c = ethyl acetate and methanol extracts of 
G. livingstonei stem bark, respectively, Fruit peel = fruit peel (methanolic) ethyl acetate extract. Data 
are representative of at three independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Response of MeWo cells to Morelloflavone, Morelloflavone-7-sulphate and Sargaol 
from Garcinia livingstonei. MeWo melanoma cells were exposed to 1-100 µM of morelloflavone 
(A), morelloflavone-7-sulphate (B), sargaol (C) or vehicle for 48 hours. Following exposure, cell 
death was then measured by LDH assay, normalized to vehicle and TX100-treated cells, and melanin 
content by absorbance at 405 nM. Each data point represents n=3 ±SEM, and is representative of at 
least three independent experiments.  
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